Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Isofol in connection with its listing on Nasdaq Stockholm
Mandate

Vinge advises Isofol in connection with its listing on Nasdaq Stockholm

October 21, 2021 Intellectual Property Capital Markets and Public M&A Commercial Agreements Employment and Benefits Corporate Tax

Vinge has advised Isofol Medical AB in connection with its listing on Nasdaq Stockholm, with the first day of trading on 21 October 2021. The prospectus was approved by the Swedish Financial Supervisory Authority on 18 October 2021. Isofol has a market value corresponding to approximately SEK 1.5 billion.

Isofol is a biotech company in late clinical phase which develops arfolitixorin in order to improve standard treatment of 5-FE based chemotherapy, primarily for advanced colorectal cancer, by increasing tumour response and progression free survival.

Vinge’s team primarily consisted of Anders Strid, Jenny Sandlund and Edin Agic (Capital Markets), Victor Ericsson and Emelie Svanberg (Tax), Anna Ståhlklo (Commercial Agreements), Alexander Lindeberg (IP) and Rebecka Hansson (Employment Law).

Related

Vinge advises Irisity in connection with issue of units

 Vinge advises Irisity AB (publ) in connection with its rights issue of units consisting of shares and warrants. The issue is guaranteed to 80 per cent through subscription commitments and external guarantors.
October 03, 2024

Vinge has advised Egetis Therapeutics in connection with directed share issuances

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with directed share issuances whereby Egetis Therapeutics receives gross proceeds of SEK 300 million.
October 03, 2024

Vinge advises Orlando Capital V in connection with the acquisition of Swedpaper AB

 Vinge has acted as legal advisor to Orlando Capital V in connection with the acquisition of Swedpaper AB, a leading European manufacturer of white sack and kraft paper used in various packaging solutions for the retail, food and construction industries. Swedpaper AB's revenue for the fiscal year 2023 amounted to over EUR 68 million.
September 30, 2024